Lotus News

We’re excited to share that Xgene Pharmaceutical has announced positive topline results from their late-phase trial of XG005, an innovative non-opioid treatment for post-surgical pain. Lotus Clinical Research, in collaboration with Evolution Research Group, was proud to support this multi-center, placebo-controlled, Phase 2b study across multiple U.S. sites. The trial showed that XG005 provided statistically … Read more

Lotus Clinical Research is proud to be featured in an exciting study in collaboration with Evolution Research Group and Gonzaba Medical Group, exploring the cognitive effects of GLP-1 agonists in patients with type 2 diabetes and obesity. This study aims to uncover potential neuroprotective benefits and address health disparities in cognitive outcomes. Stay tuned for … Read more

Lotus collaborated with ERG and Concentric in vocacapsaicin bunionectomy trial The Lotus Team is thrilled to have collaborated with both ERG and Concentric on this important trial. We are proud to have played a part in helping advance a potential new treatment for pain management. Congratulations Concentric! Evolution Research Group would like to congratulate our … Read more

Placebo Response Mitigation in Pain Clinical Trials If you are attending the Pain Therapeutics Summit in San Diego then do not miss this exciting Pre-Conference workshop held by Neil Singla, MD, Chief Scientific Officer, Lotus Clinical Research, LLC . “Placebo Response Mitigation in Pain Clinical Trials” promises to be an insightful session as Dr. Singla, a board-certified anesthesiologist shares … Read more

South Rampart Pharma Receives FDA Fast Track Designation NEW ORLEANS – South Rampart Pharma, a clinical-stage biopharmaceutical company targeting the safer treatment of pain, has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the company for SRP-001 for the treatment of acute pain. SRP-001 is a “non-opioid analgesic … Read more

Exciting News! Lotus Clinical Research is now powered by ETQ Reliance Quality Management System! We are thrilled to announce that Lotus Clinical Research has joined ETQ’s Reliance QMS. With ETQ Reliance, Lotus has digitized manual processes, centralized quality data, and automated core functions like document control and CAPA Plans. This partnership has greatly enhanced our … Read more